Evidence map›Paper›PMID 41966274›Full record

ReviewThe Journal of biological chemistry2026

HECT-type ubiquitin ligases: Emerging principles in the era of full-length structures.

Thornton J Fokkens, Blanca Baños-Jaime, Sonja Lorenz

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thornton J FokkensResearch Group "Ubiquitin Signaling Specificity", Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Blanca Baños-JaimeResearch Group "Ubiquitin Signaling Specificity", Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
Sonja LorenzResearch Group "Ubiquitin Signaling Specificity", Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. Electronic address: sonja.lorenz@mpinat.mpg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquitin coordinates a complex network of cellular pathways through covalent modification of substrates. Specificity in substrate recognition and modification choice is largely conferred by ubiquitin ligases (E3s), a highly diversified enzyme family comprising 672 members in human cells. Among these, 28 belong to the homologous to E6AP C-terminus (HECT) family, whose distinctive structural features and functional specializations have remained incompletely understood. While the catalytic principles of the defining C-terminal HECT domain are well established, the manner in which this domain is embedded and regulated within full-length enzyme contexts long remained elusive. Over the past 5 years, a series of cryogenic electron microscopy studies have yielded unprecedented insight into the overall architectures, regulation modes, as well as linkage and substrate specificities of full-length HECT-type ligases. Here, we synthesize these advances to provide an up-to-date structural framework for HECT E3 mechanisms and highlight key questions for future investigation, including implications for small-molecule discovery.

Indexed as

Ubiquitin-Protein LigasesHumansSubstrate SpecificityUbiquitin-Protein Ligasescryo electron microscopyE3enzyme mechanismposttranslational modificationsubstrate recognitionubiquitination

Identifiers

PMID41966274
PMCPMC13196369

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.